Detalles de la búsqueda
1.
A novel approach to pH-Responsive targeted cancer Therapy: Inhibition of FaDu cancer cell proliferation with a pH low insertion Peptide-Conjugated DGAT1 inhibitor.
Int J Pharm
; 657: 124132, 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38641019
2.
Targeting cancer cells in acidosis with conjugates between the carnitine palmitoyltransferase 1 inhibitor etomoxir and pH (low) insertion peptides.
Int J Pharm
; 624: 122041, 2022 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35868479
3.
Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase.
Eur J Med Chem
; 227: 113892, 2022 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34678572
Resultados
1 -
3
de 3
1
Próxima >
>>